Arixtra

NDC 67457-595 · Mylan Institutional LLC

Generic namefondaparinux sodium

Dosage formINJECTION, SOLUTION

RouteSUBCUTANEOUS

Active ingredient(s)FONDAPARINUX SODIUM

Strength10 mg/.8mL

Pharmacologic classFactor Xa Inhibitor [EPC], Factor Xa Inhibitors [MoA]

Marketing categoryNDA

Packages

67457-595-08 — 10 SYRINGE, GLASS in 1 CARTON (67457-595-08) / .8 mL in 1 SYRINGE, GLASS (67457-595-00)

J1652 — Injection, fondaparinux sodium, 0.5 mg Medicare Part B payment limit (ASP + 6%): $0.93

FDA lists these products with the same active ingredient.

11797-157 — fondaparinux sodium, 55111-678 — Fondaparinux Sodium, 55111-679 — Fondaparinux Sodium, 55111-680 — Fondaparinux Sodium, 55111-681 — Fondaparinux Sodium, 55150-230 — FONDAPARINUX SODIUM, 55150-231 — FONDAPARINUX SODIUM, 55150-232 — FONDAPARINUX SODIUM, 55150-233 — FONDAPARINUX SODIUM, 67457-582 — fondaparinux sodium, 67457-583 — fondaparinux sodium, 67457-584 — fondaparinux sodium, 67457-585 — fondaparinux sodium, 67457-592 — fondaparinux sodium, 67457-593 — fondaparinux sodium, 67457-594 — fondaparinux sodium, 70710-1514 — fondaparinux sodium, 70710-1515 — fondaparinux sodium, 70710-1516 — fondaparinux sodium, 70710-1517 — fondaparinux sodium, +7 more

From the FDA National Drug Code Directory, retrieved 2026-08-24. Product listings are submitted by labelers; FDA does not verify them.